Xenotransplantation therapies
AssigneeThe Austin Research Institute
InventorsMauro S. Sandrin, Ian F. C. McKenzie
Life of this patent
Estimating the term…
Abstract
DNA sequences encoding a porcine Gal.alpha.(1,3) galactosyl transferase and clones containing such sequences are provided. The porcine Gal.alpha.(1,3) galactosyl transferase produces the Gal.alpha.(1,3)Gal epitope on the surfaces of porcine cells. This epitope is recognized by human anti-Gal.alpha.(1,3)Gal antibodies which are responsible for hyperacute rejection of xenotransplanted pig cells, tissues and organs.
Claims8
An isolated nucleic acid molecule comprising:
- (a) the nucleic acid sequence of SEQ ID NO:1;
- or
- (b) an antisense sequence complementary to (a);
- or
- (c) both (a) and (b).
An isolated nucleic acid molecule comprising:
- (a) the nucleic acid sequence of SEQ ID NO:2;
- or
- (b) an antisense sequence complementary to (a);
- or
- (c) both (a) and (b).
Clone pPgt-4 having deposit designation number AGAL N94/9030.
Clone pPGT-2 having deposit designation number AGAL N94/9029.
Clone .lambda.PGT-g1 having deposit designation number AGAL N94/9027.
Clone .lambda.PGT-g5 having deposit designation number AGAL N94/9028.
A porcine cell comprising an inactivated porcine .alpha. (1,3) galactosyl transferase gene, said inactivated porcine .alpha. (1,3) galactosyl transferase gene comprising a wild type porcine .alpha. (1,3) galactosyl transferase sequence disrupted by a cloned mutant porcine .alpha. (1,3) galactosyl transferase sequence, wherein the cloned mutant porcine .alpha. (1,3) galactosyl transferase sequence comprises a mutation of SEQ ID NO:1, wherein the mutation is selected from the group consisting of a deletion, an insertion, a substitution, and an addition such that the cloned mutant porcine .alpha. (1,3) galactosyl transferase sequence does not encode a functional galactosyl transferase so that immune reaction of the cell with human antibodies reactive with Gal .alpha. (1,3) Gal epitooes is avoided.
A porcine cell comprising an inactivated porcine .alpha. (1,3) galactosyl transferase gene, said inactivated porcine .alpha. (1,3) galactosyl transferase gene comprising a wild type porcine .alpha. (1,3) galactosyl transferase sequence disrupted by a cloned mutant porcine .alpha. (1,3) galactosyl transferase sequence, wherein the cloned mutant porcine .alpha. (1,3) galactosyl transferase sequence comprises a mutation of SEQ ID NO:2, wherein the mutation is selected from the group consisting of a deletion, an insertion, a substitution, and an addition such that the cloned mutant porcine .alpha. (1,3) galactosyl transferase sequence does not encode a functional galactosyl transferase so that immune reaction of the cell with human antibodies reactive with Gal .alpha. (1,3) Gal epitopes is avoided.
Dependencies are inferred from the claim text.